Not all people with CLL call for therapy. Regardless of all the latest advances, the iwCLL nonetheless recommends watchful observation for individuals with asymptomatic ailment.86 This suggestion relies on no less than two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). Anda pasti harus https://raymondq642oxg0.jts-blog.com/profile